Profound Medical Corp. (PRN.TO)
9.83
-0.01
(-0.10%)
CAD |
TSX |
Oct 09, 16:00
Profound Medical Enterprise Value : 315.29M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 315.29M |
| October 08, 2026 | 315.65M |
| October 07, 2026 | 254.28M |
| October 06, 2026 | 272.55M |
| October 05, 2026 | 270.35M |
| October 02, 2026 | 261.59M |
| October 01, 2026 | 261.22M |
| September 30, 2026 | 260.86M |
| September 29, 2026 | 251.72M |
| September 28, 2026 | 263.41M |
| September 25, 2026 | 254.64M |
| September 24, 2026 | 245.51M |
| September 23, 2026 | 251.72M |
| September 22, 2026 | 257.57M |
| September 21, 2026 | 268.89M |
| September 18, 2026 | 259.76M |
| September 17, 2026 | 256.84M |
| September 16, 2026 | 255.01M |
| September 15, 2026 | 245.51M |
| September 14, 2026 | 249.53M |
| September 11, 2026 | 262.32M |
| September 10, 2026 | 255.74M |
| September 09, 2026 | 296.29M |
| September 08, 2026 | 299.21M |
| September 04, 2026 | 304.69M |
| Date | Value |
|---|---|
| September 03, 2026 | 301.04M |
| September 02, 2026 | 300.68M |
| September 01, 2026 | 301.41M |
| August 31, 2026 | 301.41M |
| August 28, 2026 | 303.23M |
| August 27, 2026 | 308.35M |
| August 26, 2026 | 317.85M |
| August 25, 2026 | 300.31M |
| August 24, 2026 | 302.50M |
| August 21, 2026 | 296.66M |
| August 20, 2026 | 288.62M |
| August 19, 2026 | 312.37M |
| August 18, 2026 | 312.73M |
| August 17, 2026 | 292.27M |
| August 14, 2026 | 292.27M |
| August 13, 2026 | 298.12M |
| August 12, 2026 | 311.27M |
| August 11, 2026 | 312.00M |
| August 10, 2026 | 328.81M |
| August 07, 2026 | 332.46M |
| August 06, 2026 | 361.69M |
| August 05, 2026 | 365.70M |
| August 04, 2026 | 385.80M |
| July 31, 2026 | 335.38M |
| July 30, 2026 | 331.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MedMira, Inc. | 59.28M |
| MedX Health Corp. | 25.07M |
| VentriPoint Diagnostics Ltd. | -- |
| Theralase Technologies, Inc. | 46.63M |
| VVT Med, Inc. | 16.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.21M |
| Revenue (Quarterly) | 3.437M |
| Total Expenses (Quarterly) | 16.64M |
| EPS Diluted (Quarterly) | -0.3633 |
| Gross Profit Margin (Quarterly) | 78.41% |
| Profit Margin (Quarterly) | -384.2% |
| Earnings Yield | -13.89% |
| Normalized Earnings Yield | -13.89 |